50242-0245
Phesgo
Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf
INJECTION, SOLUTION
Subcutaneous
HYALURONIDASE (HUMAN RECOMBINANT)
30000.0
U/15mL

PERTUZUMAB
1200.0
mg/15mL

TRASTUZUMAB
600.0
mg/15mL
50242-0245-01
1 VIAL, SINGLE-DOSE in 1 CARTON (50242-245-01) > 15 mL in 1 VIAL, SINGLE-DOSE
June 29, 2020

50242-0245-86
1 VIAL, SINGLE-DOSE in 1 CARTON (50242-245-86) > 15 mL in 1 VIAL, SINGLE-DOSE
May 3, 2021
Immunotherapy
Monoclonal Antibody
HER2
 
In Use